A Sequential Window of Opportunity Trial of Anti-PD-L1/TGF-β trap (M7824) Alone and in Combination with TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma not Associated with Human Papillomavirus Infection
Demographics (3)
- AGE - Subject age at enrollment (phv00498324.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00498331.v1.p1)
- SEX - Biological sex (phv00498318.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00498323.v1.p1)
Other (13)
- AFFECTION_STATUS - Case control status of the subject for for newly diagnosed, surgically resectable oral cavity or laryngeal squamous cell carcinoma (phv00498322.v1.p1)
- AGE_ONSET - Disease onset age (phv00498325.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00498328.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00498327.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00498317.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00498330.v1.p1)
- IS_TUMOR - Tumor status (phv00498329.v1.p1)
- SAMPLE_ID - Sample ID (phv00498326.v1.p1)
- SAMPLE_ID - Sample ID (phv00498320.v1.p1)
- SUBJECT_ID - Subject ID (phv00498321.v1.p1)
- SUBJECT_ID - Subject ID (phv00498316.v1.p1)
- SUBJECT_ID - Subject ID (phv00498319.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00498332.v1.p1)